/PRNewswire/ NeoImmuneTech, Inc. (NIT or "NeoImmuneTech"), a clinical-stage T cell-focused biopharmaceutical company, today announces the addition of two.
/PRNewswire/ During unprecedented times of crisis, there is an increasing demand in the market for software development as most businesses are now entirely.
/PRNewswire/ During unprecedented times of crisis, there is an increasing demand in the market for software development as most businesses are now entirely.